2004Unpublished venueRequires access

Multiple Myeloma and Related Disorders

Author information unavailable

Open publisher page 43 citations

Abstract

Part 1. History of multiple myeloma Epidemiology and etiology of plasma cell neoplasms Part 2. The immune system in myeloma Molecular biology and cytogenetics Biology of the malignant plasma cell Pathophysiology of myeloma bone disease Part 3. Clinical features Hematologic investigations: Morphologic and phenotypic Part 4. Biochemical and immunological investigations The role of imaging in multiple myeloma Innovative approaches for diagnosis and monitoring Differential diagnosis and prognosis Part 5. Principles of management Chemotherapy, steroids and interferon Radiotherapy Autologous stem cell transplantation Allogeneic transplantation and treatment with donor lymphocytes Supportive care Biological basis of therapy: New molecular targets Immunotherapeutic approaches Part 6. Management of bone disease Management of myeloma patients with renal failure Neurologic aspects of monoclonal gammopathy of undetermined significance, multiple myeloma, and related disorders Part 7. Monoclonal gammopathies of undetermined significance: the transition from MGUS to myeloma Solitary bone and extramedullary plasmacytoma Plasma cell leukaemia AL amyloidosis Heavy-chain diseases Waldenstroma (TM)s disease

About this research paper

What this paper is about

Part 1. History of multiple myeloma Epidemiology and etiology of plasma cell neoplasms Part 2. The immune system in myeloma Molecular biology and cytogenetics Biology of the malignant plasma cell Pathophysiology of myeloma bone disease Part 3. Clinical features Hematologic investigations: Morphologic and phenotypic Part 4. Biochemical and immunological investigations The role of imaging in multiple myeloma Innovative approaches for diagnosis and monitoring Differential diagnosis and prognosis Part 5. Principles of management Chemotherapy, steroids and interferon Radiotherapy Autologous stem cell transplantation Allogeneic transplantation and treatment with donor lymphocytes Supportive care Biological basis of therapy: New molecular targets Immunotherapeutic approaches Part 6. Management of bone disease Management of myeloma patients with renal failure Neurologic aspects of monoclonal gammopathy of undetermined significance, multiple myeloma, and related disorders Part 7. Monoclonal gammopathies of undetermined significance: the transition from MGUS to myeloma Solitary bone and extramedullary plasmacytoma Plasma cell leukaemia AL amyloidosis Heavy-chain diseases Waldenstroma (TM)s disease

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Part 1. History of multiple myeloma Epidemiology and etiology of plasma cell neoplasms Part 2. The immune system in myeloma Molecular biology and cytogenetics Biology of the malignant plasma cell Pathophysiology of myeloma bone disease Part 3. Clinical features Hematologic investigations: Morphologic and phenotypic Part 4. Biochemical and immunological investigations The role of imaging in multiple myeloma Innovative approaches for diagnosis and monitoring Differential diagnosis and prognosis Part 5. Principles of management Chemotherapy, steroids and interferon Radiotherapy Autologous stem cell transplantation Allogeneic transplantation and treatment with donor lymphocytes Supportive care Biological basis of therapy: New molecular targets Immunotherapeutic approaches Part 6. Management of bone disease Management of myeloma patients with renal failure Neurologic aspects of monoclonal gammopathy of undetermined significance, multiple myeloma, and related disorders Part 7. Monoclonal gammopathies of undetermined significance: the transition from MGUS to myeloma Solitary bone and extramedullary plasmacytoma Plasma cell leukaemia AL amyloidosis Heavy-chain diseases Waldenstroma (TM)s disease

Key concepts: Multiple myeloma, Medicine, Psychology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Multiple Myeloma and Related Disorders — Research Paper | ScholarLens